2019
DOI: 10.1007/978-1-4939-9424-3_10
|View full text |Cite
|
Sign up to set email alerts
|

The X-CGD PLB-985 Cell Model for NOX2 Structure-Function Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…Analysis of X-CGD-related mutations revealed the existence of three distinct cases defined by a total absence of NOX2 (X 0 -CGD), or by a low expression of the mutated protein correlated with a reduced oxidase activity (X minus-CGD), or finally by normal expression of NOX2 but a loss of oxidase activity (X + CGD) [345]. These alternatives provided crucial models that led to definitions of functional domains and residues in NOX2 [346]. X + CGD-related mutations mainly affect the catalytic activity of the oxidase, while the mutations responsible for X minus CGD appear to affect the proper maturation and correct folding of NOX2 [347].…”
Section: Chronic Granulomatous Diseasementioning
confidence: 99%
“…Analysis of X-CGD-related mutations revealed the existence of three distinct cases defined by a total absence of NOX2 (X 0 -CGD), or by a low expression of the mutated protein correlated with a reduced oxidase activity (X minus-CGD), or finally by normal expression of NOX2 but a loss of oxidase activity (X + CGD) [345]. These alternatives provided crucial models that led to definitions of functional domains and residues in NOX2 [346]. X + CGD-related mutations mainly affect the catalytic activity of the oxidase, while the mutations responsible for X minus CGD appear to affect the proper maturation and correct folding of NOX2 [347].…”
Section: Chronic Granulomatous Diseasementioning
confidence: 99%
“…It was shown that differentiated PLB-985 cells expressed NADPH oxidase components [ 17 , 18 ]. Antibody (7D5 monoclonal antibody) directed against the extracellular loop of gp91 phox in PLB-985 revealed that cyt b 558 should be present at the plasma membrane [ 19 ]. However, the proportion of gp91 phox at the plasma membrane or in the intracellular compartment is unknown.…”
Section: Discussionmentioning
confidence: 99%
“…However, evaluating these new therapies requires cellular models. The first described in 1993 [50], and the only cell-based model mimicking the X-CGD form, available for this purpose, was the knockout CYBB PLB-985 cell [50,51]. These cells are bi-potential and can differentiate into either granulocytic or monocytic forms.…”
Section: Nox2 Deficiency: Cellular Modelsmentioning
confidence: 99%
“…In these cells, the X chromosome-linked gp91 phox gene was disrupted by homologous recombination to generate cells that, after differentiation to granulocytes, did not generate O 2 − , reproducing the phenotype of the X 0 -CGD patients with this mutation [50]. A second method to generate mutated NOX2 PLB-985 cells was described by Beaumel et al [51]. PLB-985 cells were transfected with various NOX2 mutations, cultured, and differentiated into neutrophils or monocytes/macrophages to evaluate the impact of these mutations and to study the relationships between NOX2 structure function [51].…”
Section: Nox2 Deficiency: Cellular Modelsmentioning
confidence: 99%
See 1 more Smart Citation